Ipilimumab/nivolumabColitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1826卷 / 1期

关键词：

D O I：

10.1007/s40278-020-84632-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：185 / 185

相关论文

共 50 条

[41] NivolumabColitis and pancreatitis: case report
[J]. Reactions Weekly, 2022, 1913 (1) : 353 - 353
[42] Ipilimumab/nivolumab/nivolumabColitis and lack of efficacy
[J]. Reactions Weekly, 2024, 2005 (1) : 469 - 469
[43] NivolumabColitis and steatonecrotic hepatitis: case report
[J]. Reactions Weekly, 2017, 1638 (1) : 171 - 171
[44] Ipilimumab/nivolumabColitis, hepatotoxicity and immune-related encephalitis: 3 case reports
[J]. Reactions Weekly, 2021, 1853 (1) : 256 - 256
[45] Interferon-alpha/ipilimumab/nivolumabColitis, granulomatous lymphadenitis and psychosis: 3 case reports
[J]. Reactions Weekly, 2023, 1939 (1) : 254 - 254
[46] NivolumabColitis and large-duct cholangiopathy: case report
[J]. Reactions Weekly, 2020, 1789 (1) : 193 - 193
[47] Ipilimumab/nivolumabHepatitis: case report
[J]. Reactions Weekly, 2019, 1734 (1) : 292 - 292
[48] Ipilimumab/nivolumabHypophysitis: case report
[J]. Reactions Weekly, 2022, 1887 (1) : 396 - 396
[49] Ipilimumab/pembrolizumabIleus: case report
[J]. Reactions Weekly, 2023, 1956 (1) : 287 - 287
[50] Ipilimumab/sargramostimDermatomyositis: case report
[J]. Reactions Weekly, 2016, 1603 (1) : 158 - 158

← 1 2 3 4 5 →